Overview

* WELL Health Q2 2025 revenue grows 57% yr/yr, beating analyst expectations, per LSEG data

* Adjusted EBITDA rises 231% yr/yr, reaching C$49.7 mln, driven by organic growth, acquisitions

Outlook

* WELL reaffirms 2025 revenue guidance between C$1.40 bln to C$1.45 bln

* Company expects 2025 Adjusted EBITDA between C$190 mln to C$210 mln

* WELL aims for upper half of guidance ranges with planned acquisitions

Result Drivers

* ORGANIC GROWTH - Co attributes 57% revenue increase to organic growth and acquisitions

* HEALWELL AI CONTRIBUTION - Inclusion of HEALWELL AI added C$40.5 mln to Q2 revenue

* CANADIAN PATIENT SERVICES - Revenue from Canadian Patient Services grew 49%, driven by organic growth and acquisitions

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat C$356.67 C$354.10

Revenue mln mln (12

Analysts

)

Q2 C$0.1

Adjusted

EPS

Q2 C$25.77

Adjusted mln

Net

Income

Q2 Net C$17 mln

Income

Q2 C$49.74

Adjusted mln

EBITDA

Q2 44.5%

Adjusted

Gross

Margin

Q2 C$158.74

Adjusted mln

Gross

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* Wall Street's median 12-month price target for WELL Health Technologies Corp ( WHTCF ) is C$7.68, about 34.6% above its August 13 closing price of C$5.02

* The stock recently traded at 88 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)